BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32567934)

  • 1. miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance.
    Pang K; Song J; Bai Z; Zhang Z
    Neoplasma; 2020 Sep; 67(5):1114-1121. PubMed ID: 32567934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma.
    Hu Y; Su Y; Lei X; Zhao H; Wang L; Xu T; Guo J; Yang W; Zhang X
    Sci Rep; 2020 Sep; 10(1):14981. PubMed ID: 32917936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
    Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
    J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1.
    Hou M; Li C; Dong S
    Sci Rep; 2021 Oct; 11(1):20951. PubMed ID: 34697403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
    Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A.
    Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
    Yuan JH; Li WX; Hu C; Zhang B
    Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Serum- and Glucocorticoid-Regulated Kinase 1 Enhances Cisplatin Sensitivity of Gastric Cancer Through Suppressing the Nuclear Factor Kappa-B Signaling Pathway.
    Zhang J; Lv W; Liu Y; Fu W; Chen B; Ma Q; Gao X; Cui X
    Balkan Med J; 2021 Nov; 38(6):331-340. PubMed ID: 34860160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
    Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
    Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma.
    Zhao H; Bi T; Qu Z; Jiang J; Cui S; Wang Y
    Oncol Rep; 2014 Sep; 32(3):1003-12. PubMed ID: 25017423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
    Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L
    Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.
    Shao L; Chen Z; Soutto M; Zhu S; Lu H; Romero-Gallo J; Peek R; Zhang S; El-Rifai W
    FASEB J; 2019 Jan; 33(1):264-274. PubMed ID: 29985646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-155-5p, miR-15a, and miR-186 Expression in Gastric Cancer Is Associated with Advanced Tumor Grade and Metastasis.
    Zare A; Alipoor B; Omrani MD; Zali MR; Malekpour Alamdari N; Ghaedi H
    Iran Biomed J; 2019 Sep; 23(5):338-343. PubMed ID: 31103022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
    Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.
    Song J; Yin J; Bai Z; Zhang J; Meng H; Cai J; Deng W; Ma X; Zhang Z
    Dig Dis Sci; 2017 May; 62(5):1223-1234. PubMed ID: 28341869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.